July 30, 2020 Newly Published Research from ARUP and the U of U Explores Performance of Test Used to Diagnose Invasive Fungal Infections

Kimberly Hanson, MD, ARUP section chief of clinical microbiology and an associate professor at the University of Utah School of Medicine, led a study of serum (1-3)- β-D-glucan tests that was published in the Cochrane Database of Systematic Reviews.

Voelkerding and Wittwer

July 1, 2020 ARUP Announces the Retirements of Two Pioneering Laboratory Scientists

SALT LAKE CITY – ARUP Laboratories today announced the retirements of two pioneering scientists whose work is responsible for important advancements in laboratory medicine.

Carl Wittwer, MD, PhD, medical director of Immunologic Flow Cytometry, is retiring after 32 years at ARUP and the University of Utah School of Medicine, while Karl Voelkerding, MD, medical director of genomics and

ARUP Wellness staff

May 30, 2019 ARUP Wellness Center Wins Two Awards

Wellness staff members Curtis Bell, Shelby Firouzi, Natalie Sargent, Raven Berman, and Kelly Gibbons stand with new awards from Utah Worksite Wellness Conference.

In May, the ARUP Wellness Center won the Platinum Healthy Worksite Award and the Innovation Award for Physical Wellbeing at the Utah Worksite Wellness Conference.

An ill child awaiting treatment

March 8, 2018 New Technology Diagnoses Pneumonia Caused by Previously Undetected Pathogens

Metagenomics test identified pathogens missed by conventional lab tests in 44 percent of immunocompromised children treated for respiratory infection

A man receiving peritoneal dialysis, illustrates chronic kidney disease

February 27, 2018 Chronic Kidney Disease and Improving Diagnoses: ARUP Teams Up to Identify Patients at Risk

Thirty million people have chronic kidney disease (CKD), but only 3.6 million know they’ve got the disease. With few early symptoms, people may not realize they have the disease until their kidney function is significantly depleted. That can be fatal without dialysis or a kidney transplant.

One in three American adults is at risk for chronic kidney disease as a result of hypertension or diabetes

ARUP Statement Regarding PAMA

September 29, 2017 ARUP Statement Regarding PAMA

Last Friday, Sept 22, 2017, Centers for Medicare & Medicaid Services (CMS) released the proposed CY 2018 Medicare payment rates for laboratory tests on the Part B Clinical Laboratory Fee Schedule (CLFS). 

ARUP will be conducting a careful assessment, but upon first review, CMS outlines drastic cuts to many high volume routine test rates currently performed by numerous hospitals, small community and critical access hospital labs, physician office labs (POL), and nursing